Free Trial

Avanos Medical (AVNS) Earnings Date, Estimates & Call Transcripts

Avanos Medical logo
$14.42 +0.03 (+0.17%)
As of 11:57 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Avanos Medical Latest Earnings Summary

Upcoming Q1
Earnings Date
May. 1Before Market OpensEstimated
Actual EPS
(Feb. 26)
$0.43 Beat By $0.03
Consensus EPS
(Feb. 26)
$0.40

Avanos Medical released Q4 2024 earnings on February 26, 2025, reporting an EPS of $0.43, which topped analysts' consensus estimates of $0.40 by $0.03. Quarterly revenue was reported to be $179.60 million, above analyst estimates of $177.23 million. With a trailing EPS of -$8.53 and a P/E Ratio of 42.71, Avanos Medical's earnings are expected to grow 31.06% next year, from $1.32 to $1.73 per share.

AVNS Upcoming Earnings

Avanos Medical's next earnings date is estimated for Thursday, May 1, 2025, based off prior year's reporting schedules.

Get Avanos Medical Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Avanos Medical and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

AVNS Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

AVNS Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.
Remove Ads

Avanos Medical Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20251$0.19$0.19$0.19 
Q2 20251$0.29$0.29$0.29 
Q3 20251$0.30$0.30$0.30 
Q4 20251$0.42$0.42$0.42 
FY 20254$1.20$1.20$1.20 
Q1 20261$0.31$0.31$0.31 
Q2 20261$0.30$0.30$0.30 
Q3 20261$0.39$0.39$0.39 
Q4 20261$0.49$0.49$0.49 
FY 20264$1.49$1.49 $1.49
Remove Ads

Avanos Medical Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
5/1/2025
(Estimated)
-------
2/26/2025Q4 2024$0.40$0.43+$0.03-$8.64$177.23M$179.60M
7/31/2024Q2 2024$0.29$0.34+$0.05$0.64$170.67M$171.70M
5/2/2024Q1 2024$0.21$0.19 -$0.02$0.40$162.90M$166.10M
2/20/2024Q4 2023$0.37$0.36 -$0.01$0.49$170.43M$173.30M
11/1/2023Q3 2023$0.29$0.30+$0.01$0.68$169.60M$171.30M
8/9/2023Q2 2023$0.34$0.24 -$0.10$1.94$186.30M$169.40M
5/3/2023Q1 2023$0.28$0.27 -$0.01$0.55$195.20M$191.70M

Avanos Medical Earnings - Frequently Asked Questions

Avanos Medical has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 1st, 2025 based off last year's report dates. Learn more on AVNS's earnings history.

Avanos Medical updated its FY 2025 earnings guidance on Wednesday, February, 26th. The company provided EPS guidance of 1.050-1.250 for the period, compared to the consensus earnings per share estimate of 1.670. The company issued revenue guidance of $665.0 million-$685.0 million, compared to the consensus revenue estimate of $713.1 million.

In the previous quarter, Avanos Medical (NYSE:AVNS) reported $0.43 earnings per share (EPS) to beat the analysts' consensus estimate of $0.40 by $0.03. Learn more on analysts' earnings estimate vs. AVNS's actual earnings.

The conference call for Avanos Medical's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Avanos Medical's latest earnings report can be read online.
Read Transcript

Avanos Medical (NYSE:AVNS) has a recorded annual revenue of $687.80 million.

Avanos Medical (NYSE:AVNS) has a recorded net income of -$61.80 million. AVNS has generated -$8.53 earnings per share over the last four quarters.

Avanos Medical (NYSE:AVNS) has a trailing price-to-earnings ratio of 42.37 and a forward price-to-earnings ratio of 10.91.

Avanos Medical's earnings are expected to grow from $1.32 per share to $1.73 per share in the next year, which is a 31.06% increase.

More Earnings Resources from MarketBeat

Remove Ads


This page (NYSE:AVNS) was last updated on 3/25/2025 by MarketBeat.com Staff
From Our Partners